BACKGROUND: Human papillomavirus (HPV) and HPV-associated cancer rates are high among men who have sex with men (MSM). The US Advisory Committee on Immunization Practices recommends HPV vaccination for all MSM through age 26 years. We examined trends in HPV vaccine uptake among young US MSM between 2014 and 2017. METHODS: Cochran-Armitage tests and estimated annual percentage changes were used to examine annual trends (2014-2017) in HPV vaccination initiation among US MSM ≤26 years as of 2011 who participated in a nationwide annual cross-sectional online survey. We identified independent correlates of HPV vaccination in 2017 using Poisson regression modeling. RESULTS: There were 2,381 participants in 2014; 4,143 in 2015; 3,926 in 2016; and 3,407 in 2017. Mean age was 23.5 years, 39% lived in metropolitan areas, and 37% lived in the South. HPV vaccination significantly increased (P < 0.0001) from 22.5% in 2014 to 37.6% in 2017 (estimated annual percentage change = 17.4%). HPV vaccination was significantly greater for MSM who were younger, had health insurance, saw a healthcare provider in the past 12-months, resided in the Northeast, resided in metropolitan areas, had higher household income, disclosed their sexual identity to health care provider, and had gonorrhea/chlamydia diagnosis in the past 12-months. CONCLUSIONS: Human papillomavirus vaccination among MSM increased from 2014 to 2017, but vaccine uptake varied significantly by MSM subgroup. Despite favorable trends, the HPV vaccination coverage for this population (37.6%) is less than half of the Healthy People 2020 target (80%). Additional efforts are needed to increase coverage.
BACKGROUND:Human papillomavirus (HPV) and HPV-associated cancer rates are high among men who have sex with men (MSM). The US Advisory Committee on Immunization Practices recommends HPV vaccination for all MSM through age 26 years. We examined trends in HPV vaccine uptake among young US MSM between 2014 and 2017. METHODS: Cochran-Armitage tests and estimated annual percentage changes were used to examine annual trends (2014-2017) in HPV vaccination initiation among US MSM ≤26 years as of 2011 who participated in a nationwide annual cross-sectional online survey. We identified independent correlates of HPV vaccination in 2017 using Poisson regression modeling. RESULTS: There were 2,381 participants in 2014; 4,143 in 2015; 3,926 in 2016; and 3,407 in 2017. Mean age was 23.5 years, 39% lived in metropolitan areas, and 37% lived in the South. HPV vaccination significantly increased (P < 0.0001) from 22.5% in 2014 to 37.6% in 2017 (estimated annual percentage change = 17.4%). HPV vaccination was significantly greater for MSM who were younger, had health insurance, saw a healthcare provider in the past 12-months, resided in the Northeast, resided in metropolitan areas, had higher household income, disclosed their sexual identity to health care provider, and had gonorrhea/chlamydia diagnosis in the past 12-months. CONCLUSIONS:Humanpapillomavirus vaccination among MSM increased from 2014 to 2017, but vaccine uptake varied significantly by MSM subgroup. Despite favorable trends, the HPV vaccination coverage for this population (37.6%) is less than half of the Healthy People 2020 target (80%). Additional efforts are needed to increase coverage.
Authors: Nathan W Stupiansky; Adrian Liau; Joshua Rosenberger; Susan L Rosenthal; Wanzhu Tu; Shan Xiao; Holly Fontenot; Gregory D Zimet Journal: AIDS Patient Care STDS Date: 2017-08 Impact factor: 5.078
Authors: Sara E Oliver; Brooke E Hoots; Gabriela Paz-Bailey; Lauri E Markowitz; Elissa Meites Journal: J Acquir Immune Defic Syndr Date: 2017-07-01 Impact factor: 3.731
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Harrell W Chesson; C Robinette Curtis; Julianne Gee; Joseph A Bocchini; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2014-08-29
Authors: Peng-Jun Lu; David Yankey; Benjamin Fredua; Alissa C O'Halloran; Charnetta Williams; Lauri E Markowitz; Laurie D Elam-Evans Journal: J Pediatr Date: 2018-11-15 Impact factor: 4.406
Authors: Travis Howard Sanchez; R Craig Sineath; Erin M Kahle; Stephen James Tregear; Patrick Sean Sullivan Journal: JMIR Public Health Surveill Date: 2015-04-17
Authors: Raiza Amiling; Rachel L Winer; Michael E Newcomb; Pamina M Gorbach; John Lin; Richard A Crosby; Brian Mustanski; Lauri E Markowitz; Elissa Meites Journal: Hum Vaccin Immunother Date: 2021-12-02 Impact factor: 4.526
Authors: Mary A Gerend; Krystal Madkins; Shariell Crosby; Aaron K Korpak; Gregory L Phillips; Michael Bass; Magda Houlberg; Brian Mustanski Journal: Ann Behav Med Date: 2021-04-07
Authors: Joseph T F Lau; Zixin Wang; Tsun Kwan Mary Ip; Yebo Yu; Francois Fong; Yuan Fang; Phoenix K H Mo Journal: J Med Internet Res Date: 2021-02-02 Impact factor: 5.428
Authors: Zoe C Sullivan-Blum; Margaret Brophy; Ryan Didde; Radha Nagireddy; Hannah Swagerty; Sumiko Weir; Kevin J Sykes; Craig Dietz; Marcus Alt; Megha Ramaswamy; Paul Rotert Journal: BMJ Open Date: 2022-04-04 Impact factor: 2.692